Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02197169
Title DNX-2401 With Interferon Gamma (IFN-gamma) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors (TARGET-I)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors DNAtrix, Inc.
Indications

glioblastoma

gliosarcoma

Therapies

DNX-2401

DNX-2401 + Interferon gamma

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.